ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Mr. Michael Farrell est le Chairman of the Board de Resmed Inc, il a rejoint l'entreprise depuis 2005.
Quelle est la performance du prix de l'action RSMDF ?
Le prix actuel de RSMDF est de $25.04, il a diminué de 0.35% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Resmed Inc ?
Resmed Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Resmed Inc ?
La capitalisation boursière actuelle de Resmed Inc est de $3.6B
Est-ce que Resmed Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 19 analystes ont établi des notations d'analystes pour Resmed Inc, y compris 4 achat fort, 12 achat, 6 maintien, 0 vente et 4 vente forte